Status:

UNKNOWN

ARomatherapy for Cognitive Trajectory in Chinese After Percutaneous Coronary Intervention (ARCTIC-PCI)

Lead Sponsor:

Beijing Anzhen Hospital

Collaborating Sponsors:

Peking University

Conditions:

Percutaneous Coronary Intervention

Eligibility:

All Genders

50-75 years

Phase:

NA

Brief Summary

The ARCTIC-PCI (Aromatherapy for Cognitive Trajectory in Chinese after Percutaneous Coronary Intervention) trial is a randomized, double-blind, 2-arm, parallel group, placebo-controlled study to evalu...

Detailed Description

The ARCTIC-PCI trial has two objectives. The primary objective is to evaluate the efficacy of aromatherapy (70% menthol and 30% propanediol) in improving cognitive functions in Chinese post-PCI patien...

Eligibility Criteria

Inclusion

  • Men and women aged between 50 and 75 years old.
  • Patients with unstable angina, ST-segment elevation or non-ST elevation myocardial infarction who need stent implantation.
  • Willing to come to hospital at 3- and 6- month after PCI.
  • Signed informed consent.

Exclusion

  • Emergency patients.
  • Prior history of CABG(Coronary Artery Bypass Grafting),or other cardiac surgery.
  • Prior history of heart failure.
  • Prior history of atrial fibrillation.
  • Prior history of allergic rhinitis, sinusitis, asthma and COPD.
  • Deafness, mental illness including severe depression, and inability to communicate properly.
  • Prior history of stroke.
  • Prior history of brain tumor, traumatic brain injury, or other brain surgery.
  • Relatives of researcher or management personnel.
  • Family members been enrolled in the study.
  • Known mild cognitive impairment or dementia.
  • Mild cognitive impairment and dementia identified by cognitive function assessment before PCI.
  • Prior history of smell disorder or decreased/loss of olfactory functions assessed by the Sniffin' Sticks test.

Key Trial Info

Start Date :

December 1 2019

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 1 2021

Estimated Enrollment :

660 Patients enrolled

Trial Details

Trial ID

NCT04103086

Start Date

December 1 2019

End Date

June 1 2021

Last Update

September 30 2019

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

ARomatherapy for Cognitive Trajectory in Chinese After Percutaneous Coronary Intervention (ARCTIC-PCI) | DecenTrialz